Mylab did not see any impact on its RT-PCR (PathoDetect), rapid antigen (PathoCatch) and self-testing kits (CoviSelf).Mylab Discovery Solutions, which manufactures Covid-19 diagnostic kits, has said the new Omicron variant will have no impact on the detection efficacy of their RT-PCR, antigen or self-testing kits.
“As per the available information, key mutations in Omicron strain are located in the S-gene / spike protein. Mylab’s Covid testing kits detect entirely different and conserved regions of the coronavirus RNA, which ensures that Mylab kits can very well detect the Covid-19 infection variants – even the Omicron ones,” the company said.
Mylab did not see any impact on its RT-PCR (PathoDetect), rapid antigen (PathoCatch) and self-testing kits (CoviSelf). It said the kits can detect infection for the 12 major variants — Omicron, Beta, Zeta, Epsilon, Delta, Kappa, Gamma, Lambda, Theta, Alpha, Eta and Lota.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.